Company |
Action |
Settlement or fine |
Total |
| Wyeth |
Diet law suits
against fen-phen |
$16.6 billion set
aside for suits |
$16.6
billion |
| Pfizer |
Misuse of Neurontin,
Federal action |
$420 million |
$17.02
billion |
| Glaxo Smith Kline |
Misusing patents to
thwart generic competition to the antibiotic Augmentin |
$92 million |
$17.112
billion |
| Schering Plough |
Violation of SEC
Accounting principles/rules regarding 'corrupt' practices,
making bribes through false charity fronts |
$500,000 |
$17.117
billion |
| Bayer |
Ups settlement to
$1.06 billion for Baycol that killed 100 people,
anti-cholesterol drug...thousands of law suits still outstanding |
$1.06 billion |
$18.123
billion |
| TAP |
Illegal marketing
activities, settled in 2001 |
$875 million |
$18.998
billion |
| Schering Plough |
Kickbacks,
marketing practices for Clairtin, Medicare fraud |
$345.5
million |
$19.343
billion |
|
Glaxo Smith Kline
|
Anti-Depressant as
'suicide pill' |
Suit filed in Great
Britain |
|
| Glaxo Smith Kline |
Misuse of marketing
of Paxil, ineffective for patients under 18 |
Suit underway in New
York |
|
| Glaxo Smith Kline |
Conspiracy to
provide kickbacks for physicians recommending GSK drugs |
Suit filed in Italy |
|
| Pfizer |
Use of
anti-depressant by expectant mothers may cause withdrawl in new
borns |
In 'negotiation'
with FDA |
|
| Pfizer |
Use of
anti-depressant drove boy to kill grandparents, Pfizer aware of
effects, boy's lawyers claim |
Lawyers say Pfizer
knew of potential problems, did not take action |
|
| Abbott |
FDA, Aids Health
Foundation charge misleading advertisng in 400 % drug price
increase reasons |
Aids Health
Foundation files suit, FDA issues 'warning' |
|
